A recent study posted to the Centers for Disease Control and Prevention (CDC) Morbidity and Mortality Weekly Report (MMWR) assessed the efficacy of severe acute respiratory syndrome coronavirus 2 ...

The rapid outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus has caused the ongoing coronavirus disease 2019 (COVID-19) pandemic. Vaccination programs have commenced in ...

Our daily newsletter rounding up all of the top headlines from the DP. Get it Monday-Friday in your inbox. Free. Subscribe to get the week's top stories from The DP and beyond, meticulously curated ...

SARS-CoV-2 vaccination is thought to protect nursing home residents, as it does the general population, but data are sparse because clinical trials were not conducted in nursing homes. Investigators ...

New research assessing levels of COVID-19 antibodies (against the SARS-CoV-2 spike protein) both before vaccination and at five weeks and six months after nursing home residents received two doses of ...

White et al. (July 29 issue) 1 provided interesting data on the effectiveness of messenger RNA vaccines in reducing the incidence of SARS-CoV-2 infection in a vulnerable nursing home population. The ...

The duration and effectiveness of immunity from infection with and vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are relevant to pandemic policy interventions, ...